Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome
Eligible age
18+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this study is to evaluate whether peroneal electrical nerve stimulation (PNS) using the TOMAC™ device is a feasible, acceptable, and safe non-pharmacologic intervention for managing Restless Legs Syndrome (RLS) during pregnancy. This pilot study will also collect preliminary information on symptom relief, sleep quality, and maternal-fetal safety associated with device use. The main questions the study aims to answer are: Is TOMAC™ PNS a feasible and acceptable intervention for RLS in pregnant individuals? Are there any maternal, fetal, or neonatal safety concerns with PNS use during pregnancy? What are the patterns of adherence, tolerance, and usability of the TOMAC™ device in this population? Participants will: Use a non-invasive TOMAC™ peroneal nerve stimulator during 30-minute sessions as needed, for 8 weeks. Complete questionnaires assessing feasibility, acceptability, symptom severity, and sleep quality (including AIM, IAM, FIM, IRLS, PGI-I, PSQI, ESS, FOSQ, and MOS-II). Wear an actigraphy monitor to collect objective sleep data at baseline and at 4 weeks. Attend scheduled follow-up visits and phone check-ins for maternal vital signs, uterine contraction and fetal monitoring, and neonatal outcome assessment. This is a prospective, open-label, single-arm pilot study enrolling 15 pregnant participants between 21 and 26 weeks' gestation. Findings will provide the first dataset on the feasibility, acceptability, and safety of TOMAC™ PNS in pregnancy and inform the design of a future randomized controlled trial.
Sponsor: Rhode Island Hospital
You may qualify if…
- ✓ Age ≥18 years
- ✓ Pregnant individuals between 21 and 26 weeks' gestation at enrollment
- ✓ Singleton pregnancy without known fetal anomalies
- ✓ Confirmed clinical diagnosis of Restless Legs Syndrome (RLS) according to International Restless Legs Syndrome Study Group (IRLSSG) criteria, confirmed by a sleep medicine specialist to exclude RLS mimics
- ✓ Able and willing to provide informed consent
- ✓ Able and willing to comply with study procedures, including device usage, questionnaires, adherence diaries, and follow-up assessments up to 3 months postpartum
You may not qualify if…
- ✕ Pregnancy-related:
- ✕ History of preterm labor
- ✕ Known fetal anomalies identified prior to enrollment
- ✕ Neurological and neuromuscular disorders:
- ✕ Pre-existing neuromuscular disorders affecting balance or gait
- ✕ Severe peripheral neuropathy involving the lower legs
- ✕ Epilepsy or history of seizures
- ✕ Cardiovascular and circulatory conditions:
Where it's recruiting
Providence
Source: ClinicalTrials.gov · NCT07144631 · last updated 2025-11-12